Experiments for a systematic comparison between stable-isotope-(deuterium) labeling and radio-((14)C) labeling for the elucidation of the in vitro metabolic pattern of pharmaceutical drugs.
A systematic comparison between two labeling approaches for the investigation of the in vitro metabolic pattern of pharmaceutical drugs was performed by examining the use of (i) radiolabeled drugs analyzed with LC-MS-offline radiodetection and (ii) stable-isotope labeled drugs, used in a defined mixture with the unlabeled drug and analyzed by LC-MS with recognition of the specific isotopic pattern. (14)C was used for the radioisotope-approach and deuterium for the stable-isotope approach. Olanzapine, diclofenac and ketoconazole were chosen as model drugs, as they are commercially available in their non-, radio- and stable-isotope labeled forms. For all three model drugs, liver microsome- and hepatocyte-incubations (both from rat) were performed with various concentrations and incubation times for both, the radio- and the stable-isotope approaches. The metabolic pattern, including structure elucidation of all detected metabolites, was performed independently for all individual compounds and incubations. Subsequently, the metabolic patterns of the radio-, and the stable-isotope approaches were compared. In conclusion, all metabolites found with the radioisotope approach could also be found with the stable-isotope approach. Although the stable-isotope approach does not provide a quantitative result, it can be considered to be a highly suited analytical alternative for early in vitro metabolism investigations, especially when radiolabeled drug analogues are not yet available and quantitative results are not yet necessary.
Basilea Pharmaceutica International AG, Basel, Switzerland.
Helge
H
Grunwald
Patrick
P
Hargreaves
Klaus
K
Gebhardt
Dominique
D
Klauer
Arnaud
A
Serafyn
Anne
A
Schmitt-Hoffmann
Michael
M
Schleimer
Goetz
G
Schlotterbeck
Mathias
M
Wind
D000818:Animals; D001569:Benzodiazepines / Q000378:metabolism; D002250:Carbon Radioisotopes; D003903:Deuterium; D004008:Diclofenac / Q000378:metabolism; D022781:Hepatocytes / Q000378:metabolism; D007553:Isotope Labeling; D007654:Ketoconazole / Q000378:metabolism; D008297:Male; D008862:Microsomes, Liver / Q000378:metabolism; D000077152:Olanzapine; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
D002250:Carbon Radioisotopes; D004364:Pharmaceutical Preparations; D001569:Benzodiazepines; D004008:Diclofenac; D003903:Deuterium; D000077152:Olanzapine; D007654:Ketoconazole
Drug metabolism; Mass spectrometry; Radiolabeling; Stable-isotope labeling; Structure elucidation